Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.

PloS one - 1 Jan 2012

Delaugerre Constance, Gallien Sébastien, Flandre Philippe, Mathez Dominique, Amarsy Rishma, Ferret Samuel, Timsit Julie, Molina Jean-Michel, de Truchis Pierre

Abstract excerpt

BACKGROUND: Drug-resistance mutations (DRAM) are frequently selected in patients with virological failure defined as viral load (pVL) above 500 copies/ml (c/mL), but few resistance data are available at low-level viremia (LLV). Our objective was to determine the emergence and evolution of DRAM during LLV in HIV-1-infected patients while receiving antiretroviral therapy (ART). METHODS: Retrospective analysis of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Retroviral Agents
Share to CD4 Lymphocyte Count

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Evolution, Molecular

Share to HIV Infections

Share to Viral Load

Share to Viremia

Source

Open in PubMed Open full text

Identifiers

PMID: 22590588
DOI: 10.1371/journal.pone.0036673
PMCID: PMC3349708

Genes

GSS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients.PMID 22590588Read ↗

Drug resistance is rarely the cause or consequence of long-term persistent low-level viraemia in HIV-1-infected patients on ART.Semantic proximity Read ↗

HIV-1 persistent viremia is frequently followed by episodes of low-level viremia.Semantic proximity Read ↗

Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy.Semantic proximity Read ↗

Prevalence and Significance of HIV-1 Drug Resistance Mutations among Patients on Antiretroviral Therapy with Detectable Low-Level ViremiaSemantic proximity Read ↗

Performance of HIV-1 drug resistance testing at low-level viremia and its ability to predict future virologic outcomes and viral evolution in treatment-naive individuals.Semantic proximity Read ↗

HIV drug resistance detected during low-level viraemia is associated with subsequent virologic failure.Semantic proximity Read ↗

Drug Resistance Profile Among HIV-1 Infections Experiencing ART with Low-Level Viral Load in Guangdong China During 2011–2022: A Retrospective StudySemantic proximity Read ↗

Prevalence of drug resistance mutations in HIV-infected individuals with low-level viraemia under combination antiretroviral therapy: an observational study in a tertiary hospital in Northern Taiwan, 2017-19.Semantic proximity Read ↗

Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study.Semantic proximity Read ↗

How relevant is the HIV low level viremia and how is its management changing in the era of modern ART? A large cohort analysis.Semantic proximity Read ↗

Both baseline HIV-1 drug resistance and antiretroviral drug levels are associated with short-term virologic responses to salvage therapy.Semantic proximity Read ↗

Dynamics of drug resistance-associated mutations in HIV-1 DNA reverse transcriptase sequence during effective ART.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.